Literature DB >> 22766680

Immediate pain response to interlaminar lumbar epidural steroid administration: response characteristics and effects of anesthetic concentration.

W S Bartynski1, R B Jennings, W E Rothfus, V Agarwal.   

Abstract

BACKGROUND AND
PURPOSE: Interlaminar LESIs are commonly used to treat LBP or radiculopathy. Most studies focus on the long-term outcomes of LESI. The purpose of this study is to evaluate the immediate effects of fluoroscopically guided LESI on LBP/radiculopathy including low- or high-strength anesthetic response.
MATERIALS AND METHODS: The procedure notes, post-procedure records, and imaging records dedicated spine nurse assessments, and imaging records were retrospectively evaluated in 392 fluoroscopically guided LESIs performed in 276 patients (nonrandomized, nonblinded; 131 males, 145 females; average age, 56 years) with LBP/radiculopathy using either low- or high-strength anesthetic (80 mg of methylprednisilone mixed with bupivacaine [0.25% or 0.5%]). Post-procedure documentation of the patient's pre- and postprocedure VAS pain-scale level were tabulated.
RESULTS: Single LESI was performed in 199 patients, with multiple LESIs in 77 (193 injections). Low-strength bupivacaine (0.25%) was used in 237 injections, with high-strength (0.5%) in 155. Complete to near-complete immediate pain relief (<20% residual pain) was reported after 197 of 392 (50.3%) injections. No pain relief was reported after 60 (15.4%) injections (>80% residual), with partial relief in the remainder. No statistical difference was noted between low- and high-anesthetic strength or between single- and multiple-injection patients. In multiple-LESI patients, consistent pain relief response was noted in 39 of 77 (50.6%) patients, with improving LESI response in 20.8%, deteriorating LESI response in 19.5%, and variable response in 9.1%.
CONCLUSIONS: An immediate pain-extinction response is identified after LESI, which appears independent of anesthetic strength. This observation may relate to pain origin and/or pain nociceptor afferent pathway in an individual patient and potentially relate to treatment response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766680      PMCID: PMC7966316          DOI: 10.3174/ajnr.A3170

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  66 in total

1.  Sites of sensory blockade during segmental spinal and segmental peridural anesthesia in man.

Authors:  M J FRUMIN; H SCHWARTZ; J J BURNS; B B BRODIE; E M PAPPER
Journal:  Anesthesiology       Date:  1953-11       Impact factor: 7.892

2.  Inflammatory cytokines in the herniated disc of the lumbar spine.

Authors:  H Takahashi; T Suguro; Y Okazima; M Motegi; Y Okada; T Kakiuchi
Journal:  Spine (Phila Pa 1976)       Date:  1996-01-15       Impact factor: 3.468

3.  Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica.

Authors:  K Olmarker; B Rydevik
Journal:  Spine (Phila Pa 1976)       Date:  2001-04-15       Impact factor: 3.468

4.  Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots.

Authors:  K Olmarker; B Rydevik; C Nordborg
Journal:  Spine (Phila Pa 1976)       Date:  1993-09-01       Impact factor: 3.468

5.  A controlled immunohistochemical study of inflammatory cells in disc herniation tissue.

Authors:  M Grönblad; J Virri; J Tolonen; S Seitsalo; E Kääpä; J Kankare; P Myllynen; E O Karaharju
Journal:  Spine (Phila Pa 1976)       Date:  1994-12-15       Impact factor: 3.468

6.  Methylprednisolone reduces the early vascular permeability increase in spinal nerve roots induced by epidural nucleus pulposus application.

Authors:  G Byröd; K Otani; H Brisby; B Rydevik; K Olmarker
Journal:  J Orthop Res       Date:  2000-11       Impact factor: 3.494

7.  Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases.

Authors:  J D Kang; M Stefanovic-Racic; L A McIntyre; H I Georgescu; C H Evans
Journal:  Spine (Phila Pa 1976)       Date:  1997-05-15       Impact factor: 3.468

8.  Pathology of lumbar nerve root compression. Part 1: Intraradicular inflammatory changes induced by mechanical compression.

Authors:  Shigeru Kobayashi; Hidezo Yoshizawa; Shuuichi Yamada
Journal:  J Orthop Res       Date:  2004-01       Impact factor: 3.494

Review 9.  The role of inflammation in lumbar pain.

Authors:  J S Saal
Journal:  Spine (Phila Pa 1976)       Date:  1995-08-15       Impact factor: 3.468

10.  Do corticosteroids produce additional benefit in nerve root infiltration for lumbar disc herniation?

Authors:  Hisayoshi Tachihara; Miho Sekiguchi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Spine (Phila Pa 1976)       Date:  2008-04-01       Impact factor: 3.468

View more
  4 in total

1.  Paravertebral spinal injection for the treatment of patients with degenerative facet osteoarthropathy: Evidence of motor performance improvements based on objective assessments.

Authors:  Nima Toosizadeh; Homayoon Harati; Tzu-Chuan Yen; Cindy Fastje; Jane Mohler; Bijan Najafi; Michael Dohm
Journal:  Clin Biomech (Bristol, Avon)       Date:  2016-10-11       Impact factor: 2.063

Review 2.  Safety of Epidural Corticosteroid Injections.

Authors:  Ippokratis Pountos; Michalis Panteli; Gavin Walters; Dudley Bush; Peter V Giannoudis
Journal:  Drugs R D       Date:  2016-03

3.  Evaluation of lung function and clinical features of interlaminar cervical epidural steroid injections: a randomized controlled trial.

Authors:  Ji Seon Chae; Won-Joong Kim; Gi Year Lee; Yong Ju Choi
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

4.  Immediate Pain Relief at Time of Corticosteroid Injection for Idiopathic Adhesive Capsulitis as a Predictor of Eventual Outcomes.

Authors:  Milos Lesevic; John T Awowale; Thomas E Moran; David R Diduch; Stephen F Brockmeier; Brian C Werner
Journal:  Orthop J Sports Med       Date:  2021-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.